Statement Of Financial Position [Abstract]

BioInvent International - Filing #678852

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-01-01
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-01-01
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Right-of-use assets
23 153 SEK
26 543 SEK
Intangible assets other than goodwill
0 SEK
0 SEK
Cash and cash equivalents
259 548 SEK
515 047 SEK
515 047 SEK
910 755 SEK
Assets
1 400 180 SEK
1 712 214 SEK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
13 161 SEK
12 994 SEK
Retained earnings
2 462 691 SEK
2 135 337 SEK
Equity attributable to owners of parent
1 309 727 SEK
1 606 122 SEK
Equity
13 161 SEK
3 759 256 SEK
2 462 691 SEK
1 309 727 SEK
1,000 SEK
1,000 SEK
1 606 122 SEK
2 135 337 SEK
12 994 SEK
3 728 464 SEK
2 094 623 SEK
11 694 SEK
1 366 987 SEK
1,000 SEK
3 449 915 SEK
Equity and liabilities
1 400 180 SEK
1 712 214 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.